The Journal of the Pediatric Infectious Diseases Society today released its June issue, which includes a consensus statement of the global Sentinel Project on Pediatric Drug-Resistant Tuberculosis.
[More]
In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis bacteria in laboratory culture.
[More]
Innovative and potentially game-changing clinical trials to develop new drug regimens to prevent and treat tuberculosis, the second leading global infectious disease killer, are in jeopardy due to federal "sequestration" funding cuts.
[More]
The government of Equatorial Guinea is working to renovate all the hospitals in the country within the next four years, according to Minister of Health Tomas Mecheba Fernandez Galilea.
[More]
A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to new research published in the Journal of Infectious Diseases.
[More]
In medical school, we were taught not to withhold information from our patients or to be "paternal" in making decisions for them. We internalized the idea that fully informed patients are better equipped to make treatment decisions.
[More]
In 2011, my husband, Eric, a trial attorney, was felled by a brain stem stroke just before he was to board a flight at O'Hare in Chicago. He was just 53 years old with no prior health conditions or problems. From the outset, we knew his recovery and rehabilitation would be long and difficult. We didn't know that his transition to post-hospital medical care would be just as challenging.
[More]
Novartis announced today that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older.
[More]
Concerned that key partners in the fight against HIV & AIDS like the Global Fund to Fight AIDS, Tuberculosis and Malaria and the President's Emergency Plan for AIDS Relief are losing funding due to government cuts, AIDS Healthcare Foundation, in conjunction with Kenya AIDS NGOs Consortium, have organized a NO RETREAT ON AIDS march from Jevanjee Gardens to Uhuru Park on Friday May 10, 2013 to protest the loss of lifesaving and much-needed funding.
[More]
Researchers at the Institute of Tropical Medicine have successfully developed and tested a combination of simple clinical, radiological and laboratory tools to diagnose smear-negative tuberculosis.
[More]
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.
[More]
Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria.
[More]
"Three people die every minute from tuberculosis -- a treatable and largely preventable disease. Resistant forms continue to thrive, and increased travel makes the global threat very real. We face a public health emergency," Vince Forlenza, chair, CEO, and president of the medical technology firm Becton, Dickinson and Company, writes in the Harvard Business Review Blog Network.
[More]
"U.S. support for global health has had a major impact around the world, particularly our contributions to fighting malaria through the President's Malaria Initiative and the Global Fund to Fight AIDS, Tuberculosis, and Malaria," Rep. Ander Crenshaw (R-Fla.), co-chair of the Congressional Caucus on Malaria and Neglected Tropical Diseases, and Steve Davis, CEO of PATH, write in a Washington Times opinion piece.
[More]
Reflecting on World Immunization Week, April 21-28, Angeline Nanni, director of market access at Aeras, discusses the "remarkable results" of expanded immunization programs in a guest post on the Global Health Technologies Coalition's "Breakthroughs" blog.
[More]
The Models of Infectious Disease Agent Study is a collaborative research network funded by the National Institutes of Health that uses computational, statistical and mathematical models to understand the spread of infectious diseases such as influenza, pertussis, West Nile disease, dengue fever and cholera.
[More]
Al Jazeera's "Inside Story" on Friday examined whether funding and political will can keep pace with efforts to vaccinate every child worldwide. The 25-minute video program, "with presenter Shiulie Ghosh, discusses with guests: Kate Elder from Doctors Without Borders; Adel Mahmoud, a global health specialist at Princeton University, and former president of Merck Vaccines," Al Jazeera writes.
[More]
Mycobacterial ocular inflammation typically arises without concomitant systemic or pulmonary disease and should be suspected in patients who do not respond to anti-inflammatory therapy.
[More]
"With the globally agreed target of reversing the incidence rate of malaria by 2015 now in sight, top United Nations officials [on Thursday] urged the international community to stay committed to protecting people from this preventable disease and to scale up key interventions such as the provision of insecticide-treated mosquito nets," the U.N. News Centre reports, noting April 25 marked the annual World Malaria Day, with this year's theme, "Invest in the future. Defeat malaria."
[More]
On World Malaria Day (April 25), the U.N. "warned ... that malaria maintains its impact on less developed countries, mainly in Africa, where millions of people lack needed attention," and in a message marking the day, U.N. Secretary-General Ban Ki-moon "urged political leaders and health authorities of states where malaria is endemic to keep their commitment to achieve universal access to prevention and treatment of malaria".
[More]